Gam-COVID-Vac
AXP000170.1 · Vaccine
- Platform
- human adenovirus 26 prime, human adenovirus 5 boost (non-replicating)
- Targets
- SARS-CoV-2 S
- Originator
- Gamaleya Research Institute of Epidemiology and Microbiology
- Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology
Names
| Name | Type | Source |
|---|---|---|
| Gam-COVID-Vac | preferred name, code | curator, wikidata |
| Sputnik V | brand | wikidata |
| Gam-COVID-Vac-Lyo | code | wikidata |
| Gam-COVID-Vac-M | code | wikidata |
Virus
- Role
- Vaccine vector
- Family
- Adenoviridae
- Virus
- human adenovirus 26
- Strain
- rAd26 (dose 1); rAd5 (dose 2)
- Replication
- non replicating
- Modifications
- two non-replicating adenoviral vectors given 21 days apart, both encoding the full-length SARS-CoV-2 spike
- Transgenes
- SARS-CoV-2 spike
- Route
- intramuscular
- Source
- evidence
Approvals
| Agency | Region | Date | Status | Brand | Indication | Source |
|---|---|---|---|---|---|---|
| other | RU | 2020-08-11 | conditional | Sputnik V | Prevention of COVID-19; registration LP-006395 by the Russian Ministry of Health | source |
Clinical trials (20)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT05248373 | Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray | Unknown | Phase 1/2 | 2022-03-08 | 2023-02-14 | 400 | COVID-19; SARS-CoV-2 Acute Respiratory Disease |
| NCT04684446 | Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19 | Completed | Phase 1/2 | 2021-09-15 | 2021-11-26 | 100 | COVID-19 |
| NCT04988048 | Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina | Unknown | Phase 2 | 2021-08-03 | 2021-09-30 | 1760 | COVID-19 VACCINE; Covid19 |
| NCT05027672 | Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines. | Unknown | Phase 2 | 2021-07-30 | 2021-08-30 | 348 | COVID-19 Vaccines |
| NCT04983537 | Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population | Unknown | Phase 2 | 2021-07-26 | 2021-09-26 | 120 | COVID-19 Vaccines |
| NCT04760730 | Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19) | Completed | Phase 1/2 | 2021-07-13 | 2022-03-29 | 100 | COVID-19 |
| NCT04962906 | Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes | Completed | Phase 2 | 2021-07-05 | 2021-08-05 | 192 | COVID-19 Vaccines |
| NCT04954092 | Study of Gam-COVID-Vac in Adolescents | Unknown | Phase 2/3 | 2021-07-05 | 2022-11-06 | 3000 | Covid19; Vaccine Preventable Disease |
| NCT04871841 | Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan | Completed | 2021-04-05 | 2021-09-05 | 82 | Covid19; Vaccine Adverse Reaction | |
| NCT04834869 | COVID-19 Vaccines Safety Tracking (CoVaST) | Recruiting | 2021-04-01 | 2025-12-31 | 30000 | Adverse Reaction to Vaccine; COVID19 Vaccine | |
| NCT04686773 | Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention | Completed | Phase 2 | 2021-03-05 | 2021-10-30 | 100 | COVID-19 |
| NCT04738435 | Safety of the Sputnik V Vaccine in Health Personnel of Private Effectors of the City of Buenos Aires, Argentina | Completed | 2021-01-05 | 2021-03-01 | 600 | COVID-19 | |
| NCT04656613 | A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE | Unknown | Phase 3 | 2020-12 | 2021-08 | 1000 | Covid19; SARS-CoV Infection |
| NCT04640233 | Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection | Unknown | Phase 2/3 | 2020-11-30 | 2021-08 | 1600 | COVID-19 Prevention |
| NCT04642339 | Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela | Unknown | Phase 3 | 2020-11 | 2021-10 | 2000 | Covid19 |
| NCT04587219 | The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older | Unknown | Phase 2 | 2020-10-22 | 2021-03-30 | 110 | Coronavirus Infection |
| NCT04564716 | Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus | Unknown | Phase 3 | 2020-09-28 | 2021-03-28 | 100 | Covid19 |
| NCT04530396 | Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 | Unknown | Phase 3 | 2020-09-07 | 2021-05-01 | 33758 | Covid19 Prevention |
| NCT04437875 | An Open Study of the Safety, Tolerability and Immunogenicity of "Gam-COVID-Vac Lyo" Vaccine Against COVID-19 | Completed | Phase 1/2 | 2020-06-17 | 2020-08-03 | 38 | Preventive Immunization COVID-19 |
| NCT04436471 | An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19 | Completed | Phase 1/2 | 2020-06-17 | 2020-08-03 | 38 | Preventive Immunization COVID-19 |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 41948336 | Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial. | Frontiers in immunology | 2026 | name in abstract: Gam-COVID-Vac |
| PMID 41972135 | Sputnik V update: safety and neutralizing antibodies in healthy adults and adolescents. | Frontiers in immunology | 2026 | name in title: Sputnik V |
| PMID 42099605 | Cellular immune responses 12 months after fractional or standard dose BNT162b2 booster vaccination in Mongolian adults. | Frontiers in immunology | 2026 | name in abstract: Gam-COVID-Vac |
| PMID 42800087 | One-year antibody kinetics and effectiveness of a BNT162b2 booster after four primary COVID-19 vaccination regimens in Mongolia. | Vaccine | 2026 | name in abstract: Gam-COVID-Vac |
| PMID 39765039 | Humoral Immune Response to SARS-CoV-2 Vaccines in Patients with Autoimmune Rheumatic Diseases. | Archives of medical research | 2025 | name in abstract: Gam-COVID-Vac |
| PMID 41072276 | Immunogenicity and safety at twelve months of fractional and standard BNT162b2 booster doses in adults primed with ChAdOx1-S, BBIBP-CorV, or Gam-COVID-Vac in Mongolia: a randomised controlled trial. | Vaccine | 2025 | name in title: Gam-COVID-Vac |
| PMID 37605835 | Humoral and T Cell Response to SARS-CoV-2 Vaccination in Patients With Rheumatoid Arthritis. | Arthritis care & research | 2024 | name in abstract: Gam-COVID-Vac |
| PMID 38374372 | Short-term side effects of COVID-19 vaccines among healthcare workers: a multicenter study in Iran. | Scientific reports | 2024 | name in abstract: Sputnik V |
| PMID 38394514 | Evaluation of short-term adverse events of COVID-19 vaccines: An observational study. | Medicine | 2024 | name in abstract: Sputnik V |
| PMID 38681264 | Linear Morphea in the Context of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Unique Dermatological Manifestation. | Cureus | 2024 | name in abstract: Sputnik V |
| PMID 38807602 | Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and Argentina. | Frontiers in immunology | 2024 | name in abstract: Gam-COVID-Vac |
| PMID 39224589 | Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study. | Frontiers in immunology | 2024 | name in abstract: Sputnik V |
| PMID 39339956 | Sputnik V-Induced Antibodies against SARS-CoV-2 Variants during the Dissemination of the Gamma Variant in Venezuela. | Viruses | 2024 | cited by trial NCT04642339 |
| PMID 39417469 | [Effect of previous exposure to COVID-19, occurrence of spikes, and type of vaccine on the humoral immune response of institutionalized older adults]. | Cadernos de saude publica | 2024 | name in abstract: Sputnik V |
| PMID 35172420 | Pharmacist-directed Sputnik V (GAM-COVID-VAC) surveillance program: a prospective observational study in Southern India. | Journal of basic and clinical physiology and pharmacology | 2023 | name in title: Gam-COVID-Vac |
| PMID 36357266 | Sputnik V vaccine-related complications and its impression on inflammatory biomarkers in healthcare providers. | Indian journal of medical microbiology | 2023 | name in title: Sputnik V |
| PMID 36643729 | Acute disseminated encephalomyelitis following the COVID-19 vaccine Ad26.COV2.S, a case report. | Bulletin of the National Research Centre | 2023 | name in abstract: Sputnik V |
| PMID 36715083 | Reactive arthritis after Gam-COVID-Vac vaccination: A case report. | Modern rheumatology case reports | 2023 | name in title: Gam-COVID-Vac |
| PMID 37095378 | High-dimensional analysis of 16 SARS-CoV-2 vaccine combinations reveals lymphocyte signatures correlating with immunogenicity. | Nature immunology | 2023 | cited by trial NCT04988048 |
| PMID 37311707 | An unusual occurrence of autoimmune pancreatitis after gam-Covid-Vac (Sputnik V): A case report and literature review. | British journal of clinical pharmacology | 2023 | name in title: Gam-COVID-Vac |
| PMID 37351091 | Effectiveness of four vaccines in preventing SARS-CoV-2 infection in Almaty, Kazakhstan in 2021: retrospective population-based cohort study. | Frontiers in public health | 2023 | name in abstract: Sputnik V |
| PMID 37488541 | A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran. | BMC public health | 2023 | name in title: Sputnik V |
| PMID 37600800 | Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study. | Frontiers in immunology | 2023 | cited by trial NCT04954092 |
| PMID 37781635 | Development of Peptic Ulcer following Second Shot of Sputnik V Vaccine: A Case Report and Literature Review of Rare Side Effects of Sputnik V Vaccine. | Case reports in infectious diseases | 2023 | name in title: Sputnik V |
| PMID 38144010 | Sputnik V vaccine perception and hesitancy in a tertiary health care centre transformed to Covid-19 vaccine centre: A case study. | Journal of education and health promotion | 2023 | name in title: Sputnik V |
| PMID 34838783 | Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary-the HUN-VE study. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022 | name in abstract: Gam-COVID-Vac |
| PMID 35106967 | Myocarditis following rAd26 and rAd5 vector-based COVID-19 vaccine: case report. | ESC heart failure | 2022 | name in abstract: Sputnik V |
| PMID 35110645 | Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac). | Scientific reports | 2022 | name in title: Gam-COVID-Vac |
| PMID 35228880 | Bell's palsy after Sputnik V COVID-19 (Gam-COVID-Vac) vaccination. | Clinical case reports | 2022 | name in title: Gam-COVID-Vac |
| PMID 35271244 | [An impact of COVID-19 on the course of epilepsy]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova | 2022 | name in abstract: Sputnik V |
| PMID 35277439 | Stroke Among SARS-CoV-2 Vaccine Recipients in Mexico: A Nationwide Descriptive Study. | Neurology | 2022 | name in abstract: Gam-COVID-Vac |
| PMID 35296289 | How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany's AstraZeneca controversy. | BMC public health | 2022 | name in abstract: Sputnik V |
| PMID 35432314 | Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study. | Frontiers in immunology | 2022 | name in abstract: Gam-COVID-Vac |
| PMID 35432992 | A case of COVID-19 infection in a kidney transplant recipient after receiving the single dose of COVID-19 vaccination. | Annals of medicine and surgery (2012) | 2022 | name in abstract: Sputnik V |
| PMID 35662784 | Sputnik-V vaccine-induced panniculitis as a local reactions. | Clinical case reports | 2022 | name in title: Sputnik V |
| PMID 35760939 | An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data. | Clinical rheumatology | 2022 | name in abstract: Gam-COVID-Vac |
| PMID 35798146 | The impact of COVID-19 vaccination programme in the Republic of San Marino: Focus on effectiveness of Gam-Covid-Vac. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022 | name in title: Gam-COVID-Vac |
| PMID 35895743 | High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination. | PloS one | 2022 | cited by trial NCT04871841 |
| PMID 35915123 | Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study. | Scientific reports | 2022 | cited by trial NCT04871841 |
| PMID 35967368 | Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries. | Frontiers in immunology | 2022 | name in abstract: Gam-COVID-Vac |
| PMID 35999428 | Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan. | Clinical drug investigation | 2022 | name in abstract: Sputnik V |
| PMID 36123681 | Vaccine effectiveness against referral to hospital after SARS-CoV-2 infection in St. Petersburg, Russia, during the Delta variant surge: a test-negative case-control study. | BMC medicine | 2022 | name in abstract: Gam-COVID-Vac |
| PMID 36168698 | [Cerebral venous thrombosis associated with COVID-19]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova | 2022 | name in abstract: Sputnik V |
| PMID 36170726 | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: First Described Complication after Gam-COVID-Vac Vaccine. | Psychiatria Danubina | 2022 | name in title: Gam-COVID-Vac |
| PMID 36199926 | Shoulder Injury Related to Vaccine Administration Following Misplaced SARS-CoV-2 Vaccination: A Case Report and Review of Literature. | Journal of orthopaedic case reports | 2022 | name in abstract: Sputnik V |
| PMID 36217139 | Gam-COVID-Vac, EpiVacCorona, and CoviVac effectiveness against lung injury during Delta and Omicron variant surges in St. Petersburg, Russia: a test-negative case-control study. | Respiratory research | 2022 | name in title: Gam-COVID-Vac |
| PMID 36220018 | Safety and effectiveness of COVID-19 SPUTNIK V vaccine in dialysis patients. | Medicina | 2022 | name in title: Sputnik V |
| PMID 36225861 | Mild Facial Paresis in a Recipient of Gam-COVID-Vac Vaccine: A Case Report. | Clinical medicine insights. Case reports | 2022 | name in title: Gam-COVID-Vac |
| PMID 36415601 | Role of the immune system and possible mechanisms in COVID-19 vaccine-induced thyroiditis: Case report and literature review. | Journal of clinical and translational endocrinology case reports | 2022 | name in abstract: Sputnik V |
| PMID 36494173 | Intracranial Hypertension and Papilledema: An Unusual Complication After the Adenoviral DNA Vector-Based Coronavirus Disease 2019 Vaccination in an Air Medical Transportation Pilot. | Air medical journal | 2022 | name in abstract: Sputnik V |
| PMID 37167165 | [Non-specific prevention of COVID-19 during vaccination against a new coronavirus infection: results of a multicenter, double-blind, placebo-controlled, randomized clinical trial]. | Terapevticheskii arkhiv | 2022 | name in abstract: Gam-COVID-Vac |
| PMID 33306989 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. | Lancet (London, England) | 2021 | cited by trial NCT04738435 |
| PMID 33440088 | Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine. | The New England journal of medicine | 2021 | cited by trial NCT04738435 |
| PMID 33545094 | Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. | Lancet (London, England) | 2021 | cited by trial NCT04530396 |
| PMID 34015240 | Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient. | Human vaccines & immunotherapeutics | 2021 | name in abstract: Gam-COVID-Vac |
| PMID 34360156 | COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines' Side Effects. | International journal of environmental research and public health | 2021 | cited by trial NCT04834869 |
| PMID 34774086 | Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies. | Journal of hematology & oncology | 2021 | name in title: Gam-COVID-Vac |
| PMID 34861167 | Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia. | Cell host & microbe | 2021 | name in abstract: Sputnik V |
| PMID 32663912 | An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. | The New England journal of medicine | 2020 | cited by trial NCT04738435 |
| PMID 32896291 | Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. | Lancet (London, England) | 2020 | cited by trial NCT04436471 |
| PMID 33301246 | Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. | The New England journal of medicine | 2020 | cited by trial NCT04738435 |
| PMID 31583123 | The how's and what's of vaccine reactogenicity. | NPJ vaccines | 2019 | cited by trial NCT04738435 |
| PMID 28728074 | No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines. | Current opinion in immunology | 2017 | cited by trial NCT04738435 |
| PMID 27836435 | Vaccine safety evaluation: Practical aspects in assessing benefits and risks. | Vaccine | 2016 | cited by trial NCT04738435 |
| PMID 11061799 | Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination. | Pediatrics | 2000 | cited by trial NCT04738435 |
Other papers
Preclinical studies, reviews and other papers that name it, newest 100 shown.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 41337980 | Sustained superior humoral immune responses of mRNA vaccines compared to Sputnik V viral vector COVID-19 vaccines in naïve and convalescent populations. | Vaccine | 2026 | name in title: Sputnik V |
| PMID 41422787 | COVID-19 vaccine production and the technological gap in the Global South: The cases of Argentina and Brazil. | Vaccine | 2026 | name in abstract: Sputnik V |
| PMID 41691908 | Corrigendum to "Sustained superior humoral immune responses of mRNA vaccines compared to Sputnik V viral vector COVID-19 vaccines in naïve and convalescent populations" [Vaccine 70 (2026) 128018]. | Vaccine | 2026 | name in title: Sputnik V |
| PMID 41708421 | COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated with laboratory-confirmed SARS-CoV-2 in Ghana, June 2022 to March 2024. | Vaccine | 2026 | name in abstract: Sputnik V |
| PMID 42196551 | Impact of COVID-19 Booster Vaccination on Serum Redox Homeostasis. | International journal of molecular sciences | 2026 | name in abstract: Sputnik V |
| PMID 42594644 | Implications for future pandemics from a living systematic review and critical evaluation of observational studies of the effectiveness of COVID-19 vaccination against the Omicron variant. | Vaccine | 2026 | name in abstract: Gam-COVID-Vac |
| PMID 42731688 | Assessment of the immune response induced by ChAdOx1 nCoV-19 Oxford-AstraZeneca, Sputnik V, and BNT162b2 Pfizer-BioNTech vaccines during the COVID-19 epidemic outbreak in the Mexican population: Gene expression of the cytokine storm. | Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases | 2026 | name in title: Sputnik V |
| PMID 42898918 | Post-Vaccination Chemosensory Dysfunction: Changes Following SARS-CoV-2 Vaccination in a Global Study. | Laryngoscope investigative otolaryngology | 2026 | name in abstract: Sputnik V |
| PMID 39786643 | Globally approved vaccines for COVID-19: a systematic review. | Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] | 2025 | name in abstract: Gam-COVID-Vac |
| PMID 39843797 | Empowering African Expertise: Enhancing Safety Data Integration and Signal Detection for COVID-19 Vaccines Through the African Union Smart Safety Surveillance Joint Signal Management Group. | Drug safety | 2025 | name in abstract: Gam-COVID-Vac |
| PMID 39927226 | Impact of COVID-19 vaccination on lower urinary tract (LUTS) in benign prostatic hyperplasia (BPH) patients. | Clinical and experimental vaccine research | 2025 | name in abstract: Sputnik V |
| PMID 40006661 | Comparison of Phenotypes of Headaches After COVID-19 Vaccinations Differentiated According to the Vaccine Used. | Vaccines | 2025 | name in abstract: Sputnik V |
| PMID 40028315 | Report on adverse events of COVID-19 vaccines in Iran: a comprehensive national prospective longitudinal analysis. | Frontiers in immunology | 2025 | name in abstract: Sputnik V |
| PMID 40144475 | A comparison of Gam-COVID-Vac vaccination and non-vaccination on neurological symptoms and immune response in post-COVID-19 syndrome. | Qatar medical journal | 2025 | name in title: Gam-COVID-Vac |
| PMID 40214688 | [The effect of phycocyanins from Arthrospira platensis on the efficacy of immunization with an anti-coronavirus vaccine in vivo]. | Voprosy pitaniia | 2025 | name in abstract: Sputnik V |
| PMID 40595074 | Evaluating miscarriage incidence after COVID-19 vaccination. | Scientific reports | 2025 | name in abstract: Sputnik V |
| PMID 40706509 | Evaluation of T cell immune memory response after BBIBP-CorV, gam-COVID-Vac, and heterologous gam-COVID-Vac /mRNA-1273 COVID-19 vaccination schemes against different SARS-CoV-2 variants. | Vaccine | 2025 | name in title: Gam-COVID-Vac |
| PMID 40826472 | Adverse events of special interest after vaccination with COVID-19 vaccines: a cohort event monitoring study in Iran. | European journal of medical research | 2025 | name in abstract: Sputnik V |
| PMID 40996146 | Neighborhood enrichment for the identification of antigen-specific T-cell receptors. | Briefings in bioinformatics | 2025 | name in abstract: Sputnik V |
| PMID 41012613 | Development and Clinical Validation of a Skin Test for In Vivo Assessment of SARS-CoV-2 Specific T-Cell Immunity. | Viruses | 2025 | name in abstract: Gam-COVID-Vac |
| PMID 41019042 | Immunization route-mediated differences in long-term maturation of humoral immune response induced by adenovirus vector-based COVID-19 vaccine Sputnik V in nonhuman primates. | Frontiers in immunology | 2025 | name in title: Sputnik V |
| PMID 41113693 | Neutralization and Anti-S Antibody Titers in SARS-CoV-2 Boosted Adults in Mexico: A Comparison Across Five Vaccine Types. | International journal of microbiology | 2025 | name in abstract: Gam-COVID-Vac |
| PMID 41221172 | Autoimmune manifestations recorded after SARS-CoV-2 vaccination. | Clinical and experimental vaccine research | 2025 | name in abstract: Sputnik V |
| PMID 41550918 | Temporal dynamics of SARS-CoV-2 antibodies and IgG subclasses following multiple doses and diverse COVID-19 vaccine combinations. | Frontiers in immunology | 2025 | name in abstract: Gam-COVID-Vac |
| PMID 37899662 | Clinicopathological characteristics of cutaneous complications following COVID-19 vaccination: A case series. | Journal of cosmetic dermatology | 2024 | name in abstract: Sputnik V |
| PMID 38250868 | Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection. | Vaccines | 2024 | name in title: Gam-COVID-Vac |
| PMID 38250901 | A Potential Association between Abdominal Obesity and the Efficacy of Humoral Immunity Induced by COVID-19 and by the AZD1222, Convidecia, BNT162b2, Sputnik V, and CoronaVac Vaccines. | Vaccines | 2024 | name in title: Sputnik V |
| PMID 38312015 | Immune response to SARS-CoV-2 variants after immunization with different vaccines in Mexico. | Epidemiology and infection | 2024 | name in abstract: Sputnik V |
| PMID 38357398 | Immunogenicity, safety, and reactogenicity of a half- versus full-dose BNT162b2 (Pfizer-BioNTech) booster following a two-dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac priming schedule in Mongolia: a randomised, controlled, non-inferiority trial. | The Lancet regional health. Western Pacific | 2024 | name in title: Gam-COVID-Vac |
| PMID 38383356 | Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis. | BMC infectious diseases | 2024 | name in abstract: Gam-COVID-Vac |
| PMID 38543960 | Comparative Analysis of SARS-CoV-2 Antibody Responses across Global and Lesser-Studied Vaccines. | Vaccines | 2024 | name in abstract: Sputnik V |
| PMID 38544731 | COVID-19 vaccines breakthrough infection and adverse reactions in medical students: a nationwide survey in Iran. | Frontiers in public health | 2024 | name in abstract: Gam-COVID-Vac |
| PMID 38547193 | Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico. | PloS one | 2024 | name in abstract: Sputnik V |
| PMID 38584118 | Comparison of T cells mediated immunity and side effects of mRNA vaccine and conventional COVID-19 vaccines administrated in Jordan. | Human vaccines & immunotherapeutics | 2024 | name in abstract: Sputnik V |
| PMID 38655548 | Landscape review of active vaccine safety surveillance activities for COVID-19 vaccines globally. | Vaccine: X | 2024 | name in abstract: Gam-COVID-Vac |
| PMID 38722969 | Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon. | PloS one | 2024 | name in abstract: Sputnik V |
| PMID 38753835 | Attitude toward vaccination against COVID-19 and acceptance of the national "QazVac" vaccine in the Aktobe city population, West Kazakhstan: A cross-sectional survey. | PloS one | 2024 | name in abstract: Sputnik V |
| PMID 38793744 | The Equal Neutralizing Effectiveness of BNT162b2, ChAdOx1 nCoV-19, and Sputnik V Vaccines in the Palestinian Population. | Vaccines | 2024 | name in title: Sputnik V |
| PMID 38804309 | Humoral Immunity across the SARS-CoV-2 Spike after Sputnik V (Gam-COVID-Vac) Vaccination. | Antibodies (Basel, Switzerland) | 2024 | name in title: Gam-COVID-Vac |
| PMID 38874358 | Long-term changes in the phenotype and cytokine production of monocytes in COVID-19 recovered and vaccinated individuals. | Infection and immunity | 2024 | name in abstract: Gam-COVID-Vac |
| PMID 38880648 | Humoral and Cellular Immune Response to SARS-CoV-2 S and N Proteins. | Biochemistry. Biokhimiia | 2024 | name in abstract: Sputnik V |
| PMID 38896315 | Analysis of T-cell and Humoral Immune Response to SARS-CoV-2 Antigens in Rituximab-Treated Patients with Rheumatoid Arthritis Vaccinated with Combined Vector Vaccine Gam-COVID-Vac. | Bulletin of experimental biology and medicine | 2024 | name in title: Gam-COVID-Vac |
| PMID 38907964 | [Immunogenicity and adverse events of SARS-CoV-2 vaccine in health workers]. | Medicina | 2024 | name in abstract: Sputnik V |
| PMID 38987686 | Neutralizing antibody responses assessment after vaccination in people living with HIV using a surrogate neutralization assay. | BMC immunology | 2024 | name in abstract: Gam-COVID-Vac |
| PMID 39070079 | Assessing the Impact of COVID-19 Vaccination Programs on the Reduction of COVID-19 Cases: A Systematic Literature Review. | Annals of global health | 2024 | name in abstract: Gam-COVID-Vac |
| PMID 39100722 | COVID-19 Vaccines Breakthrough Infections and Adverse Effects Reported by the Birzeit University Community in Palestine. | International journal of general medicine | 2024 | name in abstract: Sputnik V |
| PMID 39170924 | Association of Prior COVID-19 Infection with Risk of Breakthrough Infection Following Vaccination: A Cohort Study in Isfahan, Iran. | International journal of preventive medicine | 2024 | name in abstract: Gam-COVID-Vac |
| PMID 39228552 | Post-vaccine immune status surveillance of Covishield vaccine and associated AEFI in previously SARS-Cov-2 infected seropositive and seronegative population in Assam. | Journal of family medicine and primary care | 2024 | name in abstract: Sputnik V |
| PMID 39265411 | Seroconversion in liver and intestine transplant patients after one, two or three doses of adenoviral vector vaccines against SARS-CoV-2. Single center experience in Argentina. | Human immunology | 2024 | name in abstract: Sputnik V |
| PMID 39269963 | Immunogenicity and real-world effectiveness of COVID-19 vaccines in Lebanon: Insights from primary and booster schemes, variants, infections, and hospitalization. | PloS one | 2024 | name in abstract: Sputnik V |
| PMID 39438012 | SARS-CoV-2 Infection Risk Imposed by Fully-vaccinated Air Travelers Attending an Island-confined Quarantine System Enabling Tourism During the Pandemic: A Retrospective Cohort Study. | Journal of preventive medicine and public health = Yebang Uihakhoe chi | 2024 | name in abstract: Gam-COVID-Vac |
| PMID 39460319 | Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5. | Vaccines | 2024 | name in title: Sputnik V |
| PMID 39772024 | Antibody Avidity Maturation Following Booster Vaccination with an Intranasal Adenovirus Salnavac Vaccine. | Vaccines | 2024 | name in abstract: Sputnik V |
| PMID 39959793 | Safety and Adverse Effects Related to COVID-19 Viral Vector Vaccines: A Systematic Review. | Tanaffos | 2024 | name in abstract: Sputnik V |
| PMID 35984671 | SARS-CoV-2 antibodies among health care workers from a children's hospital. | Archivos argentinos de pediatria | 2023 | name in abstract: Sputnik V |
| PMID 36124083 | The Willingness to get Vaccinated Against SARS-CoV-2 Virus among Southeast Asian Countries: Does the Vaccine Brand Matter? | Applied research in quality of life | 2023 | name in abstract: Sputnik V |
| PMID 36152219 | Assessment of the humoral response to the homologous Gam-COVID-Vac (Sputnik V) or heterologous Sputnik V/mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in dialysis patients. | Journal of nephrology | 2023 | name in title: Gam-COVID-Vac |
| PMID 36334191 | Molecular mimicry of the receptor-binding domain of the SARS-CoV-2 spike protein: from the interaction of spike-specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin. | Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine | 2023 | name in abstract: Sputnik V |
| PMID 36345267 | Neutralization of B.1.617.2 variant through antibodies elicited by ChAdOx1-S, BBIBP-CorV, and Gam-COVID-Vac in an Argentinean cohort. | Journal of medical virology | 2023 | name in title: Gam-COVID-Vac |
| PMID 36481109 | Assessing the long-stand antibody response induced by COVID-19 vaccines: A study in an educational cohort in San Luis, Argentina. | Vaccine | 2023 | name in abstract: Gam-COVID-Vac |
| PMID 36572376 | Effectiveness of COVID-19 vaccines on hospitalization and death in Guilan, Iran: a test-negative case-control study. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023 | name in abstract: Gam-COVID-Vac |
| PMID 36597426 | Safety and reported adverse effects of coronavirus disease-2019 (COVID-19) vaccines in patients with rheumatic diseases. | The Egyptian rheumatologist | 2023 | name in abstract: Sputnik V |
| PMID 36597482 | Personalized predictions of adverse side effects of the COVID-19 vaccines. | Heliyon | 2023 | name in abstract: Sputnik V |
| PMID 36602375 | Longevity and Neutralizing Capacity of IgG Antibodies against SARS-CoV-2 Generated by the Application of BNT162b2, AZD1222, Convidecia, Sputnik V, and CoronaVac Vaccines: a Cohort Study in the Mexican Population. | Microbiology spectrum | 2023 | name in title: Sputnik V |
| PMID 36728228 | Adverse events and SARS-CoV-2 antibody responses after immunization with Sputnik V, ChAdOx1-S, and BBIBP-CorV vaccines in people with HIV. | AIDS (London, England) | 2023 | name in title: Sputnik V |
| PMID 36768254 | T-Cell Immunity in COVID-19-Recovered Individuals and Individuals Vaccinated with the Combined Vector Vaccine Gam-COVID-Vac. | International journal of molecular sciences | 2023 | name in title: Gam-COVID-Vac |
| PMID 36775188 | Effectiveness of a nationwide COVID-19 vaccination program in Mexico against symptomatic COVID-19, hospitalizations, and death: a retrospective analysis of national surveillance data. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023 | name in abstract: Gam-COVID-Vac |
| PMID 36811813 | Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study. | Drug safety | 2023 | name in abstract: Sputnik V |
| PMID 36812676 | Side effects of Sputnik V, Oxford-AstraZeneca, Sinopharm, and Covaxin and their associations with other variables among healthcare workers of a tertiary hospital in Iran. | International immunopharmacology | 2023 | name in title: Sputnik V |
| PMID 36844688 | Adverse events following immunisation with the first dose of sputnik V among Iranian health care providers. | Clinical and experimental vaccine research | 2023 | name in title: Sputnik V |
| PMID 36851114 | Bell's Palsy and COVID-19 Vaccines: A Systematic Review and Meta-Analysis. | Vaccines | 2023 | name in abstract: Sputnik V |
| PMID 36851694 | Structural and Immunoreactivity Properties of the SARS-CoV-2 Spike Protein upon the Development of an Inactivated Vaccine. | Viruses | 2023 | name in abstract: Sputnik V |
| PMID 36899326 | Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system. | BMC infectious diseases | 2023 | name in title: Sputnik V |
| PMID 36932965 | Effect of the Previous History of the SARS-CoV-2 Infections on Antibody Levels among Sputnik V Vaccinated Healthcare Workers. | Iranian journal of immunology : IJI | 2023 | name in title: Sputnik V |
| PMID 36982183 | Dissection of Antibody Responses of Gam-COVID-Vac-Vaccinated Subjects Suggests Involvement of Epitopes Outside RBD in SARS-CoV-2 Neutralization. | International journal of molecular sciences | 2023 | name in title: Gam-COVID-Vac |
| PMID 36992128 | Effectiveness of Vaccination in Preventing COVID-19: A Community Study Comparing Four Vaccines. | Vaccines | 2023 | name in abstract: Gam-COVID-Vac |
| PMID 36995773 | Tracking the COVID-19 vaccines: The global landscape. | Human vaccines & immunotherapeutics | 2023 | name in abstract: Gam-COVID-Vac |
| PMID 37008741 | The effectiveness of COVID-19 vaccines in Latin America, 2021: a multicenter regional case-control study. | Lancet regional health. Americas | 2023 | name in abstract: Sputnik V |
| PMID 37070983 | Longitudinal Follow-Up of the Immunity to SARS-CoV-2 in Health Care Workers in Argentina: Persistence of Humoral Response and Neutralizing Capacity after Sputnik V Vaccination. | mSphere | 2023 | name in title: Sputnik V |
| PMID 37086551 | Impact of vaccination against the novel coronavirus infection (COVID-19) with Sputnik V on mortality during the delta variant surge. | Journal of infection and public health | 2023 | name in title: Sputnik V |
| PMID 37090429 | Comparative analysis of humoral immune response upon the three first vaccines applied in Argentina: IgG production and neutralizing capacity against SARS-CoV-2. | Heliyon | 2023 | name in abstract: Sputnik V |
| PMID 37155553 | Side Effects Comparison of Coronavirus Vaccines Among Healthcare Workers in Shoushtar, Iran. | Clinical pathology (Thousand Oaks, Ventura County, Calif.) | 2023 | name in abstract: Sputnik V |
| PMID 37193234 | Side effects after COVID-19 vaccination: a comparison between the most common available vaccines in Iran. | Iranian journal of microbiology | 2023 | name in abstract: Sputnik V |
| PMID 37202794 | Headache following vaccination against COVID-19 among healthcare workers with a history of COVID-19 infection: a cross-sectional study in Iran with a meta-analytic review of the literature. | Head & face medicine | 2023 | name in abstract: Sputnik V |
| PMID 37206589 | The comparison of SARS-CoV-2 antibody levels in medical personnel induced by different types of vaccines compared to the natural infection. | Central-European journal of immunology | 2023 | name in abstract: Sputnik V |
| PMID 37212340 | COVID-19 vaccines reduce mortality in hospitalized patients with oxygen requirements: Differences between vaccine subtypes. A multicontinental cohort study. | Journal of medical virology | 2023 | name in abstract: Gam-COVID-Vac |
| PMID 37243089 | Real-World Effectiveness of Four Types of COVID-19 Vaccines. | Vaccines | 2023 | name in abstract: Sputnik V |
| PMID 37307372 | Pharmaceutical approaches for COVID-19: An update on current therapeutic opportunities. | Acta pharmaceutica (Zagreb, Croatia) | 2023 | name in abstract: Sputnik V |
| PMID 37309454 | Antibody responses to mRNA versus non-mRNA COVID vaccines among the Mongolian population. | IJID regions | 2023 | name in abstract: Gam-COVID-Vac |
| PMID 37317161 | Evaluation of the Diagnostic Performance of Two Automated SARS-CoV-2 Neutralization Immunoassays following Two Doses of mRNA, Adenoviral Vector, and Inactivated Whole-Virus Vaccinations in COVID-19 Naïve Subjects. | Microorganisms | 2023 | name in abstract: Gam-COVID-Vac |
| PMID 37356842 | Sputnik V vaccine-related complications and inflammatory biomarkers: Correspondence. | Indian journal of medical microbiology | 2023 | name in title: Sputnik V |
| PMID 37373231 | Catalase Activity of IgGs of Patients Infected with SARS-CoV-2. | International journal of molecular sciences | 2023 | name in abstract: Sputnik V |
| PMID 37376436 | Phenotypic Changes in T and NK Cells Induced by Sputnik V Vaccination. | Vaccines | 2023 | name in title: Sputnik V |
| PMID 37376648 | Functional Characteristics of Serum Anti-SARS-CoV-2 Antibodies against Delta and Omicron Variants after Vaccination with Sputnik V. | Viruses | 2023 | name in title: Sputnik V |
| PMID 37379532 | Serological response to SARS-CoV-2 vaccines in patients with multiple sclerosis in Argentina. | Medicina | 2023 | name in abstract: Sputnik V |
| PMID 37436412 | [Development and preservation of specific T-cell immunity after COVID-19 or vaccination against this infection]. | Voprosy virusologii | 2023 | name in abstract: Sputnik V |
| PMID 37445671 | Antigenic Cartography Indicates That the Omicron BA.1 and BA.4/BA.5 Variants Remain Antigenically Distant to Ancestral SARS-CoV-2 after Sputnik V Vaccination Followed by Homologous (Sputnik V) or Heterologous (Comirnaty) Revaccination. | International journal of molecular sciences | 2023 | name in title: Sputnik V |
| PMID 37456210 | Side Effects of Sputnik V Vaccine in the Medical Staff of Dedicated COVID-19 Hospital. | Iranian journal of medical sciences | 2023 | name in title: Sputnik V |
| PMID 37469916 | Adverse Events among Beneficiaries who Received a Dose of Sputnik V Vaccine at a Tertiary Care Hospital in Coastal Karnataka, India. | Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine | 2023 | name in title: Sputnik V |
| PMID 37543972 | [The most common gastrointestinal alterations in patients with post-COVID syndrome]. | Orvosi hetilap | 2023 | name in abstract: Sputnik V |
Notes
Sputnik V: heterologous two-dose regimen, rAd26 encoding the full-length SARS-CoV-2 spike on day 0 and rAd5 encoding the same spike on day 21. Marketed as one product, so one program per spec section 1; virus.tsv records the first dose's Ad26 vector and the Ad5 boost is in modifications. Registered in Russia on 11 August 2020 (licence LP-006395), a conditional registration before phase 3 results; the freeze-dried Gam-COVID-Vac-Lyo received a separate certificate LP-006423 on 26 August 2020, and Gam-COVID-Vac-M covers adolescents. Authorised in many other countries, not all listed here.
How to cite
Gam-COVID-Vac (AXP000170.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000170.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.